JNJ Congressional Disclosures Explained: Johnson & Johnson Trades Across Chambers

JNJ congressional disclosures show up in both House and Senate Periodic Transaction Reports (PTRs) because Johnson & Johnson is a long-held healthcare and consumer staple in diversified portfolios. In the last 90 days, ProBors shows a mix of purchases and sales filed between mid-June and early September 2026, with filing lag ranging from about two weeks to well over 100 days on older trades disclosed in late batches. This spotlight walks through recent Johnson & Johnson rows, how to read healthcare mega-cap PTRs, and what the record does not prove. It is research context, not investment advice.

Why JNJ appears in congress trackers

Johnson & Johnson sits in index funds, dividend portfolios, and healthcare sector allocations—so PTR rows on the name are common without implying policy foresight. Useful questions on JNJ are narrower:

• Which members filed Johnson & Johnson activity in the last 90 days?
• Was each row a purchase, partial sale, or full sale?
• How many days passed between the transaction date and the public filing date?
• Does the amount range suggest a small rebalance or a larger position change?
• Did House and Senate filings cluster in the same calendar window?

A ticker spotlight should answer those fields from source-backed rows, then let you decide whether deeper chart or insider review is warranted.

Recent JNJ filings in ProBors

The table below reflects Johnson & Johnson PTR rows in ProBors as of September 12, 2026, sorted by filing date (newest first). Filing lag is calendar days between the transaction date and the filed date as reported in ProBors. Rows are deduplicated on politician, transaction type, dates, amount, and chamber.

Snapshot summary (filed since mid-June 2026): 8 deduplicated JNJ PTR rows in this window—3 purchases and 5 sales; 4 House and 4 Senate. Median filing lag on rows filed in the normal window: 16 days (range 13–27 days). One additional Senate sale from 2024 appeared in an August 2026 batch with a much longer lag and is omitted from the table above.

Always verify individual rows against the official source before citing them:

• House PTR search: disclosures-clerk.house.gov
• Senate eFD search: efdsearch.senate.gov

Cross-chamber patterns worth noting

Three patterns stand out in this Johnson & Johnson sample—and none of them are trading signals on their own.

1. Recent Senate sales alongside House activity

Sen. John Boozman filed a JNJ sale on September 11, 2026, about 22 days after an August 20 trade date. In the same 90-day window, Rep. Richard Dean Dr McCormick and Rep. Thomas H. Jr. Kean filed House sales with shorter lags of 13–16 days. Mixed directions across chambers are normal on a mega-cap healthcare name; the research task is to read each row on its own terms rather than infer a single congressional view on JNJ.

2. Filing lag varies more than transaction type

Rep. McCormick’s July sale posted in roughly two weeks. Sen. Alan Armstrong’s March purchases did not appear until July 21, 2026—lags of 113 and 116 days. That spread is why congressional trackers must show both dates; see the STOCK Act filing delay guide for the legal 30/45-day framework and why late batches still surface.

3. Amount ranges cluster at the smallest bracket

Most rows in this window fall in the $1,001 – $15,000 band, which often reflects portfolio rebalancing rather than a large concentrated bet. Rep. Doggett’s June purchase and Sen. Armstrong’s larger March purchase bracket are useful contrasts when you compare disclosed size—not headline dollar totals. See why congressional amount ranges are not exact dollars for how to read those bands.

How to research JNJ on ProBors

Use a ticker-first workflow when Johnson & Johnson is already on your watchlist:

1. Open Market → JNJ (or search JNJ in the dashboard).
2. Scroll to the Congress trades table and sort by filed date.
3. Click a row to open trade context—transaction type, amount range, chamber, and signal tier.
4. Toggle congress markers on the price chart to see where disclosures landed relative to daily bars.
5. Cross-check Form 4 / whale activity on the same ticker before treating a PTR row as isolated.
6. Add JNJ to a watchlist if you want alerts on the next filing—not on live price.

For chart marker details, see the market chart congress markers guide. For researching the same ticker across both chambers, see how to research a ticker across House and Senate.

What this JNJ data does not prove

A congressional disclosure table on Johnson & Johnson does not prove:

• That members traded on non-public information
• That JNJ will rise or fall because a PTR was filed
• Exact share counts or dollar proceeds (ranges are bands, not precise fills)
• Real-time intent—most rows in this sample posted days or weeks after the transaction date
• Committee influence or healthcare policy outcomes tied to a single trade line

PTR data is a public record for transparency, not a timing edge. The useful output is a verified research trail: who filed, what type, when it traded, when it became public, and how that row compares to other disclosures on the same ticker.

FAQ

How often do members disclose JNJ trades?

Johnson & Johnson appears regularly in PTRs because it is a widely held dividend and healthcare name. Frequency depends on portfolio activity—not on a fixed calendar. ProBors lets you filter by ticker and sort by filed date to see the latest rows without manual portal searches.

Why do some JNJ rows show filing lags over 100 days?

Late batches happen when older trades are disclosed together in a single Senate filing. Sen. Armstrong’s March 2026 purchases filed in July are an example. Always compare transaction date and filing date; a long lag does not mean the trade was secret—it means the public record arrived later.

Are JNJ congressional trades mostly buys or sells?

In the last 90 days of filings reviewed here, sales outnumbered purchases (5 sales vs. 3 purchases across 8 deduplicated rows). That mix can change quickly with the next filing batch and should not be read as a congressional consensus on the stock.

Can I set alerts for new JNJ PTR rows?

Yes. Add JNJ to a ProBors watchlist and configure notification preferences for new congressional disclosures. Alerts fire on filing activity, not on live market prices—see the watchlist alerts guide for setup steps.

How does JNJ compare to other healthcare tickers in congress filings?

UNH, LLY, PFE, and ABBV also appear frequently in PTRs. A ticker spotlight on JNJ is a starting point; use ProBors filters to compare disclosure volume and filing lag across healthcare names when you need sector context.

Track JNJ and healthcare disclosures on ProBors

Filter congressional trades by ticker, chamber, and filing date—then cross-check insider and market context in one workspace.

Get started

Related reading

• How to read politician trade disclosures
• Track congress stock trades by ticker
• House stock trading tracker
• Senate stock trading tracker
• STOCK Act filing delay explained

Sources

• U.S. House Clerk — Financial Disclosure Reports
• U.S. Senate eFD — Search Financial Disclosures
• Congress.gov — STOCK Act overview
• SEC — Form 4 insider reporting
• Rows were checked in ProBors and should be verified against the original filing.
• Ingestion health: probors.com/status